Home › Cases › Acute-on-Chronic Liver Failure
Acute Liver Failure
Acute-on-Chronic Liver Failure
6 questions
Question 1 · ACLF definition
Correct answer: Acute-on-chronic liver failure (ACLF) — acute deterioration of chronic liver disease with organ failure. High short-term mortality
Why
ACLF (EASL-CLIF definition): acute decompensation of cirrhosis with organ failure (renal, liver, coagulation, cerebral, circulatory, respiratory). ACLF grade 1-3 based on number of organ failures. 28-day mortality: 25-45% (grade 1), 45-60% (grade 2), >75% (grade 3). Distinguished from acute liver failure (ALF) which occurs in previously healthy liver.
Key point
ACLF: acute deterioration of cirrhosis with organ failures. CLIF-C ACLF score. 28-day mortality up to 75% in grade 3.
Question 2 · Precipitants
Correct answer: Infection (SBP, pneumonia, UTI — 30%), alcohol excess, GI bleed, hepatotoxic drugs, surgery, dehydration
Why
ACLF precipitants: infection (most common — SBP in 20-30%), alcohol-related (especially active drinking), GI haemorrhage, hepatitis reactivation (HBV, HCV), drug-induced liver injury, surgery, large volume paracentesis without albumin. Identify and treat precipitant to improve prognosis.
Key point
ACLF precipitants: infection (SBP most common), alcohol, GI bleed, hepatitis reactivation. Always identify and treat cause.
Question 3 · Liver transplant
Correct answer: Urgent liver transplant assessment. ACLF grade 2-3 with MELD >25 may benefit from transplant. Short listing window — deteriorates fast
Why
ACLF and liver transplant: ACLF grade 2-3 without severe non-hepatic organ failure may benefit from transplant. MELD >28-30 with ACLF: urgent transplant listing discussion. However: infection, haemodynamic instability, renal failure may preclude transplant. Discuss with regional hepatology/transplant centre early.
Key point
ACLF grade 2-3: urgent transplant centre discussion. Short window. Contraindications: active sepsis, haemodynamic instability.
Question 4 · Hepatorenal syndrome
Correct answer: Hepatorenal syndrome (HRS-AKI) — functional renal failure in cirrhosis from splanchnic vasodilation → renal vasoconstriction
Why
Hepatorenal syndrome: functional renal failure in cirrhosis without structural kidney disease. Criteria: creatinine >133, absence of other cause (not pre-renal/post-renal/intrinsic), no response to 2-day albumin challenge (20% albumin 1g/kg up to 100g/day). Management: terlipressin + albumin.
Key point
HRS: functional renal failure in cirrhosis. Creatinine rising + no response to albumin. Terlipressin + albumin.
Question 5 · Terlipressin in HRS
Correct answer: Vasopressin analogue: splanchnic vasoconstriction → reverses the portal hypertension-induced vasodilation → improves renal perfusion pressure
Why
Terlipressin mechanism: V1 receptor vasopressin analogue → splanchnic vasoconstriction → reduces portal pressure → improves effective circulating volume → reverses renal vasoconstriction → renal perfusion improves. Given with IV albumin (maintains oncotic pressure). CONFIRM trial confirmed benefit vs noradrenaline.
Key point
Terlipressin: splanchnic vasoconstriction → reverses portal hypertension physiology → improves renal perfusion. + albumin.
Question 6 · Hepatic encephalopathy
Correct answer: Lactulose (reduce intestinal ammonia), rifaximin, identify and treat precipitants (infection, constipation, GI bleed, electrolytes), avoid sedatives, nutritional support
Why
Hepatic encephalopathy: treat precipitant (most important), lactulose 30-50ml BD-TDS (target 2-3 soft stools/day), rifaximin (prevents recurrence), correct electrolytes, treat SBP. Protein restriction is outdated — cirrhotic patients need adequate protein (1.2g/kg/day) to maintain muscle mass. Avoid opioids and benzodiazepines.
Key point
Hepatic encephalopathy: lactulose + rifaximin, treat precipitant. Adequate protein (NOT restriction). Avoid sedatives.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.